Advancers (with shrs traded post-mkt):
- CRCM +18.1% (1k); Google Capital Invests $46.35m
- SGY +7.9% (33k); Ends Ensco Pact, Signs Midstream Contract
- CIT +6% (13k); Laurentian to Buy CIT Canada Financing Unit
- SSTK +3.8% (141k); Named to S&P 600
- TWLO +3.3% (290k); Closed at Highest Since Last Week’s IPO
- MGT +3.2% (240k); Adds to 23% Regular-Session Gain
- CLVS +2.3% (26k); Rose 22% in Regular Session
- C +2.2% (821k); Plans $8.6b Buyback, Div. Boost to 16c
- ALLY +1.9% (35k); Inaugural Div., $700m Buyback Planned
- BAC +1.7% (3.6m); $5b Buyback; Boosts Div to 7.5c
- JPM +1.5% (760k); $10.6b Buyback, Maintains Div. at 48c
- GS +1.4% (94k); Plans Buyback, Div. Boost
- LNT +1.2% (12k); Set to Join S&P 500
- CPHD +1.2% (20k); Infection-Control Aid Cleared by FDA
- MS +1.1% (290k); Up to $3.5b Buyback; Boosts Div. to 20c
- HBAN +1.1% (110k); Will Lift Div. to 8c
- BK +1.1% (109k); Plans $2.7b Buyback, Boosts Dividend
- DB +1.1% (132k); Says U.S. Capital Adequacy Not in Doubt
- SWX +1% (6k); Moving Up to S&P MidCap 400
- RF +1% (259k); May Buy Back Up to $640m, Boost Div.
- PRGS +5.2% (11k)
Decliners:
- ICPT -5.3% (39k); $400m Convertible Offering
- SAN -3.1% (55k); U.S. Unit Fails Stress Test for 3rd Year
- TSCO -7.5% (263k)
- PIR -6.8% (254k)